ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Jeil Pharmaceutical Co., Ltd. clinical trials

Part of Jeil Pharma Holdings Inc., which holds 49.24% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 57 studies whose lead sponsor is Jeil Pharmaceutical Co., Ltd. or the company grouped under it. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Jeil Pharmaceutical with AstraZeneca and Merck →

Pipeline: 4 programs

Each counted once: 4 with a study Jeil Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Jeil Pharmaceutical Co., Ltd.’s own registered studies; Jeil Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Jeil Pharmaceutical Co., Ltd.’s studies test, most open studies first — 14 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 4 more

Coming up

1 of Jeil Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 57 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1221%Not yet recruiting 7 · Recruiting 5
  • Under way, not recruiting12%
  • Completed3968%
  • Status unknown or other59%

Phase

  • Phase 131
  • Phase 312
  • Phase 28
  • Phase 41

Where

  • Korea, Republic of49
  • France1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 817
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 626

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Jeil Pharmaceutical Co., Ltd.

  • Jeil Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    38 studies
  • Onconic Therapeutics Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →

Studies

Recruiting first, then most recently updated. Showing 50 of 57. Browse all 57 →